We found a double mutation (DM) in 6 patients, with one carrying a DM in MUTYH and the other 5 harboring mutations in MUTYH and other cancer susceptibility genes (CHEK2, BRIP1, MLH1, and BRCA1). The gene discussed is CHEK2; the disease is cancer.